Canton Biotechnologies Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Canton Biotechnologies General Information

Description

Developer of innovative wound healing technology designed to provide high-value therapeutics. The company's technology uses CA5 HIF plasmid transfection with electroporation, thereby enabling patients and health institutions to avail fast and effective cures to accelerate wound healing in acute and chronic wounds.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 2601 Boston Street
  • Suite 606
  • Baltimore, MD 21224
  • United States
+1 (410) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Canton Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Feb-2021 0000 Completed Generating Revenue
4. Grant 01-Jan-2015 00000 0000 Completed Generating Revenue
3. Early Stage VC 17-Aug-2006 0000 0000 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Spin-Off 01-Jan-2004 Completed Startup
To view Canton Biotechnologies’s complete valuation and funding history, request access »

Canton Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
John Harmon MD President
You’re viewing 1 of 2 executive team members. Get the full list »

Canton Biotechnologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute of General Medical Sciences Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Canton Biotechnologies’s complete investors history, request access »

Canton Biotechnologies FAQs

  • When was Canton Biotechnologies founded?

    Canton Biotechnologies was founded in 2004.

  • Who is the founder of Canton Biotechnologies?

    David Pyrce is the founder of Canton Biotechnologies.

  • Where is Canton Biotechnologies headquartered?

    Canton Biotechnologies is headquartered in Baltimore, MD.

  • What industry is Canton Biotechnologies in?

    Canton Biotechnologies’s primary industry is Discovery Tools (Healthcare).

  • Is Canton Biotechnologies a private or public company?

    Canton Biotechnologies is a Private company.

  • What is Canton Biotechnologies’s current revenue?

    The current revenue for Canton Biotechnologies is 000000.

  • How much funding has Canton Biotechnologies raised over time?

    Canton Biotechnologies has raised $80K.

  • Who are Canton Biotechnologies’s investors?

    National Institute of General Medical Sciences, United States Department of Defense, and Johns Hopkins Technology Ventures have invested in Canton Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »